We here propose that the mechanism underlying this effect is not only due to the reported ability of probiotics in reducing endotoxemia [39, 40, 41] but also to the specific antiinflammatory effect of S. clausii SF174 spores mediated by increased portal levels of IL‐10. The gene discussed is IL10; the disease is serum lipopolysaccharide activity.